Entity Common Stock, Shares Outstanding of Autolus Therapeutics plc from Q3 2018 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Autolus Therapeutics plc quarterly Entity Common Stock, Shares Outstanding history and change rate from Q3 2018 to Q3 2025.
  • Autolus Therapeutics plc Entity Common Stock, Shares Outstanding for the quarter ending 11 Nov 2025 was 266M shares, a 0.01% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Autolus Therapeutics plc Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 266M +21.6K +0.01% 11 Nov 2025 10-Q 12 Nov 2025
Q2 2025 266M +47K +0.02% 11 Aug 2025 10-Q 12 Aug 2025
Q1 2025 266M +203K +0.08% 19 Mar 2025 10-K 20 Mar 2025
Q3 2024 266M +92.1M +53% 08 Nov 2024 10-Q 12 Nov 2024
Q2 2024 266M 06 Aug 2024 10-Q 08 Aug 2024
Q1 2024 266M 20 Mar 2024 10-K 21 Mar 2024
Q3 2023 174M 09 Nov 2023 10-Q 09 Nov 2023
Q4 2022 173M +82.2M +90.4% 31 Dec 2022 20-F 07 Mar 2023
Q4 2021 90.9M +38.6M +73.7% 31 Dec 2021 20-F 10 Mar 2022
Q4 2020 52.3M +7.36M +16.4% 31 Dec 2020 20-F 04 Mar 2021
Q4 2019 45M +4.84M +12.1% 31 Dec 2019 20-F 03 Mar 2020
Q4 2018 40.1M 31 Dec 2018 20-F 25 Feb 2019
Q3 2018 40.1M 30 Sep 2018 20-F 23 Nov 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.